asia morning nov 10
While the Nasdaq 100 tumbles over 2%...
Share this:
On Monday, U.S. stocks gave up most of early gains to close mixed. The Dow Jones Industrial Average soared over 1600 points at open but closed 834 points higher (+2.95%) at 29158. The S&P 500 rose 41 points (+1.17%) to 3550, while the Nasdaq 100 tumbled 260 points (-2.16%) to 11830.
S&P 500 Index (Daily Chart) : Bullish Gap
Sources: GAIN Capital, TradingView
Market sentiment was boosted by the fact that a COVID-19 vaccine being developed by Pfizer (PFE +7.68%) and BioNTech (BNTX +13.91%) was found to be over 90% effective.
Energy (+14.22%), Banks (+13.2%) and Insurance (+5.63%) sectors performed the best, while Retailing (-3.3%), Household & Personal Products (-3.1%) and Semiconductors & Semiconductor Equipment (-1.83%) sectors lagged behind. Energy companies such as Diamondback Energy (FANG +30.96%), National Oilwell Varco (NOV +27.33%) and Valero Energy (VLO +31.2%) became top gainers amid an 8% jumped in oil prices.
Amazon.com (AMZN -5.06%) slid.
Approximately 72% (75% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 62% (68% in the prior session) were trading above their 20-day moving average.
European stocks closed substantially higher. The Stoxx Europe 600 jumped 3.98%, Germany's DAX surged 4.94%, France's CAC 40 soared 7.57%, and the U.K.'s FTSE 100 was up 4.67%.
U.S. Treasury bonds encountered a selloff as positive news on Pfizer's COVID-19 vaccine drove investors into riskier assets such as stocks. The benchmark 10-year Treasury yield surged to 0.955% from 0.817% Friday.
Spot gold plunged $83 (-4.29%) to $1,867 an ounce..
U.S. WTI crude futures (December) advanced $2.82 (+7.59%) to $39.96 a barrel.
The U.S. dollar regained some strength against other major currencies, as a breakthrough in coronavirus vaccine diminished expectations of more economic stimulus measures. The ICE Dollar Index rebounded 0.65% to 92.82.
The Japanese yen and the Swiss franc were the worst performers among major currencies. USD/JPY soared 1.95% to 105.37, and USD/CHF rebounded 1.39% to 0.9127.
EUR/USD slid 0.50% to 1.1813 halting a four-day rally.
GBP/USD climbed for a third session as it edged up to 1.3165 from 1.3159 Friday.
AUD/USD rose 0.33% to 0.7282 (day-high at 0.7340).
USD/CAD once lost the 1.3000 level before closing at 1.3008, down 0.23% on day.
S&P 500 Index (Daily Chart) : Bullish Gap
Sources: GAIN Capital, TradingView
Market sentiment was boosted by the fact that a COVID-19 vaccine being developed by Pfizer (PFE +7.68%) and BioNTech (BNTX +13.91%) was found to be over 90% effective.
Energy (+14.22%), Banks (+13.2%) and Insurance (+5.63%) sectors performed the best, while Retailing (-3.3%), Household & Personal Products (-3.1%) and Semiconductors & Semiconductor Equipment (-1.83%) sectors lagged behind. Energy companies such as Diamondback Energy (FANG +30.96%), National Oilwell Varco (NOV +27.33%) and Valero Energy (VLO +31.2%) became top gainers amid an 8% jumped in oil prices.
Amazon.com (AMZN -5.06%) slid.
Approximately 72% (75% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 62% (68% in the prior session) were trading above their 20-day moving average.
European stocks closed substantially higher. The Stoxx Europe 600 jumped 3.98%, Germany's DAX surged 4.94%, France's CAC 40 soared 7.57%, and the U.K.'s FTSE 100 was up 4.67%.
U.S. Treasury bonds encountered a selloff as positive news on Pfizer's COVID-19 vaccine drove investors into riskier assets such as stocks. The benchmark 10-year Treasury yield surged to 0.955% from 0.817% Friday.
Spot gold plunged $83 (-4.29%) to $1,867 an ounce..
U.S. WTI crude futures (December) advanced $2.82 (+7.59%) to $39.96 a barrel.
The U.S. dollar regained some strength against other major currencies, as a breakthrough in coronavirus vaccine diminished expectations of more economic stimulus measures. The ICE Dollar Index rebounded 0.65% to 92.82.
The Japanese yen and the Swiss franc were the worst performers among major currencies. USD/JPY soared 1.95% to 105.37, and USD/CHF rebounded 1.39% to 0.9127.
EUR/USD slid 0.50% to 1.1813 halting a four-day rally.
GBP/USD climbed for a third session as it edged up to 1.3165 from 1.3159 Friday.
AUD/USD rose 0.33% to 0.7282 (day-high at 0.7340).
USD/CAD once lost the 1.3000 level before closing at 1.3008, down 0.23% on day.
On Monday, U.S. stocks gave up most of early gains to close mixed. The Dow Jones Industrial Average soared over 1600 points at open but closed 834 points higher (+2.95%) at 29158. The S&P 500 rose 41 points (+1.17%) to 3550, while the Nasdaq 100 tumbled 260 points (-2.16%) to 11830.
S&P 500 Index (Daily Chart) : Bullish Gap
Sources: GAIN Capital, TradingView
Market sentiment was boosted by the fact that a COVID-19 vaccine being developed by Pfizer (PFE +7.68%) and BioNTech (BNTX +13.91%) was found to be over 90% effective.
Energy (+14.22%), Banks (+13.2%) and Insurance (+5.63%) sectors performed the best, while Retailing (-3.3%), Household & Personal Products (-3.1%) and Semiconductors & Semiconductor Equipment (-1.83%) sectors lagged behind. Energy companies such as Diamondback Energy (FANG +30.96%), National Oilwell Varco (NOV +27.33%) and Valero Energy (VLO +31.2%) became top gainers amid an 8% jumped in oil prices.
Amazon.com (AMZN -5.06%) slid.
Approximately 72% (75% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 62% (68% in the prior session) were trading above their 20-day moving average.
European stocks closed substantially higher. The Stoxx Europe 600 jumped 3.98%, Germany's DAX surged 4.94%, France's CAC 40 soared 7.57%, and the U.K.'s FTSE 100 was up 4.67%.
U.S. Treasury bonds encountered a selloff as positive news on Pfizer's COVID-19 vaccine drove investors into riskier assets such as stocks. The benchmark 10-year Treasury yield surged to 0.955% from 0.817% Friday.
Spot gold plunged $83 (-4.29%) to $1,867 an ounce..
U.S. WTI crude futures (December) advanced $2.82 (+7.59%) to $39.96 a barrel.
The U.S. dollar regained some strength against other major currencies, as a breakthrough in coronavirus vaccine diminished expectations of more economic stimulus measures. The ICE Dollar Index rebounded 0.65% to 92.82.
The Japanese yen and the Swiss franc were the worst performers among major currencies. USD/JPY soared 1.95% to 105.37, and USD/CHF rebounded 1.39% to 0.9127.
EUR/USD slid 0.50% to 1.1813 halting a four-day rally.
GBP/USD climbed for a third session as it edged up to 1.3165 from 1.3159 Friday.
AUD/USD rose 0.33% to 0.7282 (day-high at 0.7340).
USD/CAD once lost the 1.3000 level before closing at 1.3008, down 0.23% on day.
S&P 500 Index (Daily Chart) : Bullish Gap
Sources: GAIN Capital, TradingView
Market sentiment was boosted by the fact that a COVID-19 vaccine being developed by Pfizer (PFE +7.68%) and BioNTech (BNTX +13.91%) was found to be over 90% effective.
Energy (+14.22%), Banks (+13.2%) and Insurance (+5.63%) sectors performed the best, while Retailing (-3.3%), Household & Personal Products (-3.1%) and Semiconductors & Semiconductor Equipment (-1.83%) sectors lagged behind. Energy companies such as Diamondback Energy (FANG +30.96%), National Oilwell Varco (NOV +27.33%) and Valero Energy (VLO +31.2%) became top gainers amid an 8% jumped in oil prices.
Amazon.com (AMZN -5.06%) slid.
Approximately 72% (75% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 62% (68% in the prior session) were trading above their 20-day moving average.
European stocks closed substantially higher. The Stoxx Europe 600 jumped 3.98%, Germany's DAX surged 4.94%, France's CAC 40 soared 7.57%, and the U.K.'s FTSE 100 was up 4.67%.
U.S. Treasury bonds encountered a selloff as positive news on Pfizer's COVID-19 vaccine drove investors into riskier assets such as stocks. The benchmark 10-year Treasury yield surged to 0.955% from 0.817% Friday.
Spot gold plunged $83 (-4.29%) to $1,867 an ounce..
U.S. WTI crude futures (December) advanced $2.82 (+7.59%) to $39.96 a barrel.
The U.S. dollar regained some strength against other major currencies, as a breakthrough in coronavirus vaccine diminished expectations of more economic stimulus measures. The ICE Dollar Index rebounded 0.65% to 92.82.
The Japanese yen and the Swiss franc were the worst performers among major currencies. USD/JPY soared 1.95% to 105.37, and USD/CHF rebounded 1.39% to 0.9127.
EUR/USD slid 0.50% to 1.1813 halting a four-day rally.
GBP/USD climbed for a third session as it edged up to 1.3165 from 1.3159 Friday.
AUD/USD rose 0.33% to 0.7282 (day-high at 0.7340).
USD/CAD once lost the 1.3000 level before closing at 1.3008, down 0.23% on day.
Related tags:
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
Gold Price Forecast: XAU/USD Plunges 12.4% Toward Critical Support 10 1 2026
Softer inflation has revived expectations for a Fed pause, but Friday’s payrolls could put gold’s recovery prospects to the test.
Dow Jones forecast: Stock markets under pressure from multiple sources
When looking at the major tech-heavy US indices like the S&P 500 or the Nasdaq 100, you wouldn’t think that the stock market is particularly weak. Yet, beneath the surface, the market is far from healthy right now. Investors are evidently just piling into the big tech and AI names, and as a result, market breadth is deteriorating. Other indices like the small cap Russell 2000 and the Dow Jones are starting to reflect that weakness.
Nikkei breakout accelerates as yen weakness returns
Nikkei has started October with a powerful breakout, helped by renewed yen weakness and strong upside momentum
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.